Overview: Tissue Transglutaminase IgA TestIntroduction: The Tissue Transglutaminase IgA Test detects tTG IgA to diagnose celiac disease, causing diarrhea or weight loss. Aligned with 2023 AGA guidelines, it uses immunoassays for high specificity, supporting autoimmune screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in immunology for patients with suspected celiac disease.
Other Names: tTG IgA Assay, Anti-tTG IgA Test.
FDA Status: Laboratory-developed test (LDT), meeting immunology standards for diagnostic accuracy.
Historical Milestone: tTG IgA testing began in the 1990s with celiac research. Immunoassay methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects tTG IgA to diagnose celiac disease, guides treatment, and evaluates patients with diarrhea or weight loss.
Test Parameters: 1. tTG IgA Antibodies
Pretest Condition: No fasting required. Collect serum or saliva. Report history of diarrhea, weight loss, or gastrointestinal symptoms.
Specimen: Serum (SST, 2-5 mL), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document diarrhea, weight loss, or history of celiac disease. Include current medications, especially gluten exposure.
Consent: Written consent required, detailing the tests purpose, celiac disease implications, and risks of sample collection.
Procedural Considerations: Uses enzyme-linked immunosorbent assay (ELISA) to detect tTG IgA antibodies. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for celiac disease diagnosis.
Factors Affecting Result Accuracy: Sample hemolysis or IgA deficiency can affect results. Gluten-free diet may cause false negatives.
Clinical Significance: Positive tTG IgA confirms celiac disease, guiding gluten-free diet or further testing. Negative results may require tTG IgG or biopsy.
Specialist Consultation: Consult a gastroenterologist for result interpretation and treatment planning.
Additional Supporting Tests: tTG IgG, endomysial antibodies, or small bowel biopsy to confirm celiac disease diagnosis.
Test Limitations: Non-specific in IgA deficiency; clinical correlation is needed. Sample quality affects sensitivity.
References: AGA Celiac Disease Guidelines, 2023; Gastroenterology, Rubio-Tapia A, 2022.
